The bridge charts on the right show operating profit of 3Q. Operating profit decreased ¥2.1 billion, excluding ¥8.7 billion, from forex impact, additional U.S.-China tariffs, structural reform and other temporary expenses, and CRE Strategy. In Office Business, operating profit declined due to the impact of a temporary deterioration in the sales mix and delays in production cost reduction remaining in 3Q. In professional print, although the impact of delays in cost reductions remained, profits turned upward. Sales of Healthcare Business remained at the same level as the previous fiscal year. In Industrial Business, profits declined mainly due to lower sales in materials and components, but the extent of the decline was restrained by productivity improvements and other factors. In New Business, operating profit increased ¥1.4 billion, reflecting higher sales of Bio-healthcare and Workplace Hub and cost controls in line with the top line.
Operating profit decreased ¥2.1 billion, excluding ¥8.7 billion, from forex impact, additional U.S.-China tariffs, structural reform and other temporary expenses, and CRE Strategy.
In Office Business, operating profit declined due to the impact of a temporary deterioration in the sales mix and delays in production cost reduction remaining in 3Q.
In professional print, although the impact of delays in cost reductions remained, profits turned upward.
Sales of Healthcare Business remained at the same level as the previous fiscal year. In Industrial Business, profits declined mainly due to lower sales in materials and components, but the extent of the decline was restrained by productivity improvements and other factors.
In New Business, operating profit increased ¥1.4 billion, reflecting higher sales of Bio-healthcare and Workplace Hub and cost controls in line with the top line.